← Back
$TERN All transactions

Terns Pharmaceuticals, Inc.

▲ BUY
9 / 10

Conviction

$ Value

$90K

Shares

23,314

Price

$4

Filed

Jun 25

Why this score? (9/10)
  • Open market buy (+3)
  • % of holdings >= 20% (+2)
  • C-suite insider (+2)
  • Director (+1)
  • Not a 10b5-1 plan (+1)

Insider

Name

Burroughs Amy L.

Title

Chief Executive Officer

CIK

0001872564

Roles

Director Officer

Transaction Details

Transaction Date

2025-06-25

Code

P

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

47,083

Footnotes

Includes 4,160 shares acquired by the reporting person under the Issuer's 2021 Employee Stock Purchase Plan on May 31, 2025.

Filing Info

Accession No.

0001562180-25-005077

Form Type

4

Issuer CIK

0001831363

Burroughs Amy L.'s History

Date Ticker Type Value
2026-02-17 TERN M $68K
2026-02-17 TERN $89K
2026-02-17 TERN $320K
2026-02-17 TERN $163K
2026-02-17 TERN M $0
2026-01-15 TERN M $126K
2026-01-15 TERN M $126K
2026-01-15 TERN M $68K
2026-01-15 TERN $2.3M
2026-01-15 TERN $282K

Other Insiders at TERN (90d)

Insider Bought Sold Last
FELLOWS DAVID A 2026-02-01
KINDLER JEFFREY B 2026-02-01
Turner Heather D 2026-02-01
Azelby Robert 2026-02-01
Tripuraneni Radhika 2026-02-01
Quigley Jill M. 2026-02-01
Burroughs Amy L.
Chief Executive Officer
$572K 2026-02-17
Kuriakose Emil
Chief Medical Officer
$50K 2026-04-01